Synthetic heparin and heparan sulfate oligosaccharides and their protein interactions

Current Opinion in Chemical Biology

Volumn 17, Issue 6, 2013, Pages 1023-1029

  Zulueta, Medel Manuel L ^a   Lin, Shu Yi ^a   Hu, Yu Peng ^a   Hung, Shang Cheng ^a,b  

^a GENOMICS RESEARCH CENTER   (Taiwan)

^b NATIONAL CHIAO TUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARAN SULFATE; HEPARIN; HYDROXYL GROUP; OLIGOSACCHARIDE; PROTEOHEPARAN SULFATE;

COMPETITIVE INHIBITION; FLUORESCENCE RESONANCE ENERGY TRANSFER; GLYCOSYLATION; ISOTHERMAL TITRATION CALORIMETRY; NONHUMAN; OXIDATION; PROTEIN INTERACTION; REVIEW; SOLID PHASE EXTRACTION; STEREOCHEMISTRY; STRUCTURE ACTIVITY RELATION; SULFONATION; SURFACE PLASMON RESONANCE; SYNTHESIS;

ANIMALS; DRUG DISCOVERY; HEPARIN; HEPARITIN SULFATE; HUMANS; MODELS, MOLECULAR; OLIGOSACCHARIDES; PROTEINS;

EID: 84890171360     PISSN: 13675931     EISSN: 18790402     Source Type: Journal    
DOI: 10.1016/j.cbpa.2013.10.008     Document Type: Review

References (54)

1. Häcker U., Nybakken K., Perrimon N. Heparan sulphate proteoglycans: the sweet side of development. Nat Rev Mol Cell Biol 2005, 6:530-541.
2. Couchman J.R., Pataki C.A. An introduction to proteoglycans and their localization. J Histochem Cytochem 2012, 60:885-897.
3. Eriksson A.S., Spillmann D. The mutual impact of syndecan-1 and its glycosaminoglycan chains-a multivariable puzzle. J Histochem Cytochem 2012, 60:936-942.
4. Choi Y., Chung H., Jung H., Couchman J.R., Oh E.-S. Syndecans as cell surface receptors: unique structure equates with functional diversity. Matrix Biol 2011, 30:93-99.
5. Bishop J.R., Schuksz M., Esko J.D. Heparan sulphate proteoglycans fine-tune mammalian physiology. Nature 2007, 446:1030-1037.
6. Esko J.D., Selleck S.B. Order out of chaos: assembly of ligand binding sites in heparan sulfate. Annu Rev Biochem 2002, 71:435-471.
7. Gandhi N.S., Mancera R.L. The structure of glycosaminoglycans and their interactions with proteins. Chem Biol Drug Res 2008, 72:455-482.
8. Petitou M., van Boeckel C.A.A. A synthetic antithrombin III binding pentasaccharide is now a drug! What comes next?. Angew Chem Int Ed 2004, 43:3118-3133.
9. Rabenstein D.L. Heparin and heparan sulfate: structure and function. Nat Prod Rep 2002, 19:312-331.
10. van Boeckel C.A.A., Petitou M. The unique antithrombin III binding domain of heparin: a lead to new synthetic antithrombotics. Angew Chem Int Ed Engl 1993, 32:1671-1690.
11. Wang Z., Ly M., Zhang F., Zhong W., Suen A., Hickey A.M., Dordick J.S., Linhardt R.J. E. coli K5 fermentation and the preparation of heparosan, a bioengineered heparin precursor. Biotechnol Bioeng 2010, 107:964-973.
12. Li P., Sheng J., Liu Y., Li J., Liu J., Wang F. Heparosan-derived heparan sulfate/heparin-like compounds: one kind of potential therapeutic agents. Med Res Rev 2013, 33:665-692.
13. Peterson S., Frick A., Liu J. Design of biologically active heparan sulfate and heparin using an enzyme-based approach. Nat Prod Rep 2009, 26:610-627.
14. Poletti L., Lay L. Chemical contributions to understanding heparin activity: synthesis of related sulfated oligosaccharides. Eur J Org Chem 2003, 2099-3024.
15. Noti C., Seeberger P.H. Chemical approaches to define the structure-activity relationship of heparin-like glycosaminoglycans. Chem Biol 2005, 12:731-756.
16. Bonnaffé D. Bioactive synthetic heparan sulfate and heparin derivatives: from long fragments mimetics to chimeras. C R Chim 2011, 14:59-73.
17. Dulaney S.B., Huang X. Strategies in synthesis of heparin/heparan sulfate oligosaccharides: 2000-present. Adv Carbohydr Chem Biochem 2012, 67:95-136.
18. Linhardt R.J., Liu J. Synthetic heparin. Curr Opin Pharmacol 2012, 12:217-219.
19. Orgueira H.A., Bartolozzi A., Schell P., Seeberger P.H. Conformational locking of the glycosyl acceptor for stereocontrol in the key step in the synthesis of heparin. Angew Chem Int Ed 2002, 41:2128-2131.
20. Zulueta M.M.L., Lin S.-Y., Lin Y.-T., Huang C.-J., Wang C.-C., Ku C.-C., Shi Z., Chyan C.-L., Irene D., Lim L.-H. Glycosylation by d-glucosamine-derived donors: synthesis of heparosan and heparin analogues that interact with mycobacterial heparin-binding hemagglutinin. J Am Chem Soc 2012, 134:8988-8995.
21. Wang Z., Xu Y., Yang B., Tiruchinapally G., Sun B., Liu R., Dulaney S., Liu J., Huang X. Preactivation-based, one-pot combinatorial synthesis of heparin-like hexasaccharides for the analysis of heparin-protein interactions. Chem Eur J 2010, 16:8365-8375.
22. Zulueta M.M.L., Zhong Y.-Q., Hung S.-C. Synthesis of l-hexoses and their related biomolecules. Chem Commun 2013, 49:3275-3287.
23. Hung S.-C., Lu X.-A., Lee J.-C., Chang M.D.-T., Fang S.-L., Fan T.-C., Zulueta M.M.L., Zhong Y.-Q. Synthesis of heparin oligosaccharides and their interaction with eosinophil-derived neurotoxin. Org Biomol Chem 2012, 10:760-772.
24. Bindschädler P., Adibekian A., Grünstein D., Seeberger P.H. De novo synthesis of differentially protected l-iduronic acid glycosylating agents. Carbohydr Res 2010, 345:948-955.
25. Hansen S.U., Baráth M., Salameh B.A.B., Pritchard R.G., Stimpson W.T., Gardiner J.M., Jayson G.C. Scalable synthesis of l-iduronic acid derivatives via stereocontrolled cyanohydrin reaction for synthesis of heparin-related disaccharides. Org Lett 2009, 11:4528-4531.
26. Cole C.L., Hansen S.U., Baráth M., Rushton G., Gardiner J.M., Avizienyte E., Jayson G.C. Synthetic heparan sulfate oligosaccharides inhibit endothelial cell functions essential for angiogenesis. PLoS ONE 2010, 5:e11644.
27. Hansen S.U., Miller G.J., Jayson G.C., Gardiner J.M. First gram-scale synthesis of a heparin-related dodecasaccharide. Org Lett 2013, 15:88-91.
28. Maza S., Macchione G., Ojeda R., Lopez-Prados J., Angulo J., de Paz J.L., Nieto P.M. Synthesis of amine-functionalized heparin oligosaccharides for the investigation of carbohydrate-protein interactions in microtiter plates. Org Biomol Chem 2012, 10:2146-2163.
29. Schwörer R., Zubkova O.V., Turnbull J.E., Tyler P.C. Synthesis of a targeted library of heparan sulfate hexa- to dodecasaccharides as inhibitors of β-secretase: potential therapeutics for Alzheimer's disease. Chem Eur J 2013, 19:6817-6823.
30. Zong C., Venot A., Dhamale O., Boons G.-J. Fluorous supported modular synthesis of heparan sulfate oligosaccharides. Org Lett 2013, 15:342-345.
31. Baleux F., Loureiro-Morais L., Hersant Y., Clayette P., Arenzana-Seisdedos F., Bonnaffé D., Lortat-Jacob H. A synthetic CD4-heparan sulfate glycoconjugate inhibits CCR5 and CXCR4 HIV-1 attachment and entry. Nat Chem Biol 2009, 5:743-748.
32. Tanaka H., Tateno Y., Takahashi T. Convergent stereoselective synthesis of multiple sulfated GlcNα(1,4)GlcAα(1,4) dodecasaccharides. Org Biomol Chem 2012, 10:9570-9582.
33. Tiruchinapally G., Yin Z., El-Dakdouki M., Wang Z., Huang X. Divergent heparin oligosaccharide synthesis with preinstalled sulfate esters. Chem Eur J 2011, 17:10106-10112.
34. Hu Y.-P., Zhong Y.-Q., Chen Z.-G., Chen C.-Y., Shi Z., Zulueta M.M.L., Ku C.-C., Lee P.-Y., Wang C.-C., Hung S.-C. Divergent synthesis of 48 heparan sulfate-based disaccharides and probing the specific sugar-fibroblast growth factor-1 interaction. J Am Chem Soc 2012, 134:20722-20727.
35. Hu Y.-P., Lin S.-Y., Huang C.-Y., Zulueta M.M.L., Liu J.-Y., Chang W., Hung S.-C. Synthesis of 3-O-sulfonated heparan sulfate octasaccharides that inhibit the herpes simplex virus type 1 host-cell interaction. Nat Chem 2011, 3:557-563.
36. Arungundram S., Al-Mafraji K., Asong J., Leach F.E., Amster I.J., Venot A., Turnbull J.E., Boons G.-J. Modular synthesis of heparan sulfate oligosaccharides for structure-activity relationship studies. J Am Chem Soc 2009, 131:17394-17405.
37. Muñoz-García J.C., López-Prados J., Angulo J., Díaz-Contreras I., Reichardt N., de Paz J.L., Martín-Lomas M., Nieto P.M. Effect of the substituents of the neighboring ring in the conformational equilibrium of iduronate in heparin-like trisaccharides. Chem Eur J 2012, 18:16319-16331.
38. Yang B., Yoshida K., Yin Z., Dai H., Kavunja H., El-Dakdouki M.H., Sungsuwan S., Dulaney S.B., Huang X. Chemical synthesis of a heparan sulfate glycopeptide: syndecan-1. Angew Chem Int Ed 2012, 51:10185-10189.
39. Zhou X., O'Leary T.R., Xu Y., Sheng J., Liu J. Chemoenzymatic synthesis of heparan sulfate and heparin. Biocatal Biotransform 2012, 30:296-308.
40. Burkart M.D., Izumi M., Chapman E., Lin C.-H., Wong C.-H. Regeneration of PAPS for the enzymatic synthesis of sulfated oligosaccharides. J Org Chem 2000, 65:5565-5574.
41. Zhou X., Chandarajoti K., Pham T.Q., Liu R., Liu J. Expression of heparan sulfate sulfotransferases in Kluyveromyces lactis and preparation of 3'-phosphoadenosine-5'-phosphosulfate. Glycobiology 2011, 21:771-780.
42. Xu Y., Wang Z., Liu R., Bridges A.S., Huang X., Liu J. Directing the biological activities of heparan sulfate oligosaccharides using a chemoenzymatic approach. Glycobiology 2012, 22:96-106.
43. 13C-labeled heparan sulfate analogue as a tool to study protein/heparan sulfate interactions by NMR spectroscopy: application to the CXCL12α chemokine. J Am Chem Soc 2011, 133:9642-9645.
44. Chen M., Bridges A., Liu J. Determination of the substrate specificities of N-acetyl-d-glucosaminyltransferase. Biochemistry 2006, 45:12358-12365.
45. Liu R., Xu Y., Chen M., Weïwer M., Zhou X., Bridges A.S., DeAngelis P.L., Zhang Q., Linhardt R.J., Liu J. Chemoenzymatic design of heparan sulfate oligosaccharides. J Biol Chem 2010, 285:34240-34249.
46. Liu R., Liu J. Enzymatic placement of 6-O-sulfo groups in heparan sulfate. Biochemistry 2011, 50:4382-4391.
47. Sheng J., Xu Y., Dulaney S.B., Huang X., Liu J. Uncovering biphasic catalytic mode of C5-epimerase in heparan sulfate biosynthesis. J Biol Chem 2012, 287:20996-21002.
48. Xu D., Moon A.F., Song D., Pedersen L.C., Liu J. Engineering sulfotransferases to modify heparan sulfate. Nat Chem Biol 2008, 4:200-202.
49. Nguyen T.K.N., Arungundram S., Tran V.M., Raman K., Al-Mafraji K., Venot A., Boons G.-J., Kuberan B. A synthetic heparan sulfate oligosaccharide library reveals the novel enzymatic action of d-glucosaminyl 3-O-sulfotransferase-3a. Mol Biosyst 2012, 8:609-614.
50. Xu Y., Masuko S., Takieddin M., Xu H., Liu R., Jing J., Mousa S.A., Linhardt R.J., Liu J. Chemoenzymatic synthesis of homogeneous ultralow molecular weight heparins. Science 2011, 334:498-501.
51. Xu Y., Pempe E.H., Liu J. Chemoenzymatic synthesis of heparin oligosaccharides with both anti-factor Xa and anti-factor IIa activities. J Biol Chem 2012, 287:29054-29061.
52. Fan T.-C., Fang S.-L., Hwang C.-S., Hsu C.-Y., Lu X.-A., Hung S.-C., Lin S.-C., Chang M.D.-T. Characterization of molecular interactions between eosinophil cationic protein and heparin. J Biol Chem 2008, 283:25468-25474.
53. García-Mayoral M.F., Canales Á., Díaz D., López-Prados J., Moussaoui M., de Paz J.L., Angulo J., Nieto P.M., Jiménez-Barbero J., Boix E., et al. Insights into the glycosaminoglycan-mediated cytotoxic mechanism of eosinophil cationic protein revealed by NMR. ACS Chem Biol 2012, 8:144-151.
54. Hecht M.-L., Rosental B., Horlacher T., Hershkovitz O., De Paz J.L., Noti C., Schauer S., Porgador A., Seeberger P.H. Natural cytotoxicity receptors NKp30, NKp44 and NKp46 bind to different heparan sulfate/heparin sequences. J Proteome Res 2009, 8:712-720.